Adrenocortical carcinoma: A 15-year survival after complete resection and repeated resection. A retrospective study in a patient with an expected poor prognosis

Anticancer Research

Volumn 23, Issue 3 C, 2003, Pages 2929-2931

  Orlando, Rocco ^b   Pelizzo, Maria Rosa ^b   Lirussi, Flavio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b NONE

Author keywords

Adrenocortical carcinoma; Case report; Prognosis

Indexed keywords

ADRENAL CORTEX CARCINOMA; ADRENALECTOMY; ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CASE REPORT; CLINICAL FEATURE; EARLY DIAGNOSIS; FOLLOW UP; HUMAN; LABORATORY TEST; MALE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REOPERATION; RETROSPECTIVE STUDY; SURVIVAL TIME;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDIES;

EID: 0042123524     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wooten MD and King DK: Adrenal cortical carcinoma: Epidemiology and treatment with mitotane and a review of the literature. Cancer 72: 3145-55, 1993.
2. Grondal S, Codermark B, Eriksson B, Grimelius L, Harach R, Kristoffersson A, Rastad J and Uden P: Adrenocortical carcinoma: a retrospective study of a rare tumor with a poor prognosis. Eur J Surg Oncol 16: 500-506, 1990.
3. Dackiw APB, Lee JE, Cagel RF and Evans DB: Adrenal cortical carcinoma. World J Surg 25: 914-26, 2001.
4. Favia G, Lumachi F and D'Amico D: Adrenocortical carcinoma: is prognosis different in nonfunctioning tumors? Results of surgical treatment in 31 patients. World J Surg 25: 735-38, 2001.
5. McFarlane DA: Cancer of adrenal cortex. The natural history, prognosis and treatment in a study of 55 cases. Ann R Coll Engl 23: 155-86, 1958.
6. Sullivan M, Boileau M and Hodges CU: Adrenal cortical carcinoma. J Urol 120: 660-65, 1978.
7. Henley DJ, van Heerden JA, Grant CS, Carney JA and Carpenter PC: Adrenal cortical carcinoma: a continuing challenge. Surgery 94: 926-31, 1983.
8. Soreide JA, Brabrand K and Thoresen S: Adrenal cortical carcinoma in Norway, 1970-1984. World J Surg 16: 663-67, 1992.
9. Haak HR, Hermans J, van de Velde CJ, Lentjies EG, Goslings BM, Fleuren GJ and Krans HM: Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. Br J Cancer 69: 947-51, 1994.
10. Zografos GC, Driscoll D, Karalousis C, Rao U and Huben R: Staging and grading in the survival of adrenal carcinoma. Eur J Surg Oncol 20: 449-53, 1994.
11. Crucitti F, Bellantone R, Ferrante A, Boscherini M and Crucitti P: The ACC Italian Registry Study Group. The Italian registry for adrenal cortical carcinoma: analysis of a multiinstitutional series of 129 patients. Surgery 119: 161-70, 1996.
12. Harrison LE, Gaudin PB and Brennan MF: Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection. Arch Surg 134: 181-5, 1999.
13. Schulick R and Brennan M: Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol 6: 719-26, 1999.
14. Icard P, Goudet P, Charpenay C, Andreassian B, Carnaille B, Chapuis Y, Cougard P, Henry J-F and Proye C: Adrenocortical carcinomas: surgical trends and results of 253-patient series from the French Association of Endocrine Surgeons Study Group. World J Surg 25: 891-7, 2001.
15. Pommier RF and Brennan MF: An eleven-year experience with adrenocortical carcinoma. Surgery 112: 963-70, 1992.
16. Richie JP and Gittes RF: Carcinoma of the adrenal cortex. Cancer 45: 1957-64, 1980.
17. Cohn K, Gottesman L and Brennan M: Adrenal carcinoma. Sugery 100: 1170-77, 1986.
18. Kopf D, Goretzki PE and Lehnert H: Clinical management of malignant adrenal tumors. J Cancer Res Clin Oncol 127: 143-5, 2001.
19. Bulger AR and Correa RJ: Experience with adrenal carcinoma. Urology 10: 12-8, 1977.
20. Luton J, Cerdas S, Billaud L, Thomas G, Guillaume B, Bertagna X. Laudat MH, Louvel A, Chapuis Y, Blondeau P, Bonnin A and Bricaire H: Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 322: 1195-1201, 1990.
21. Bellantone R, Ferrante A, Boscherini M, Lombardi CP, Crucitti P, Crucitti F, Favia G, Borrelli D, Boffi L, Capussotti L, Carbone G, Casaccia M, Cavallaro A, Del Gaudio A, Dettori G, Di Giovanni V, Mazziotti A, Marrano D, Masenti E, Miccoli P, Mussa A, Petronio R, Piat G, Maranzano L et al: Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for adrenal cortical carcinoma. Surgery 122: 1212-18, 1997.